Minimal Change Disease Latest Advances
Find the Latest Research About Minimal Change Disease
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4754 publications
The endoplasmic reticulum resident molecular chaperone, GRP170, is required to maintain podocyte homeostasis and function.
Journal: American journal of physiology. Renal physiology
Published: October 26, 2026
Progressive Actomyosin Remodeling Defining a Structured Podocyte Injury Response in Nephrotic Syndrome.
Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026
Corrigendum to "Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis." Kidney International 2023;103,565-579.
Journal: Kidney international
Published: October 20, 2026
The value of immuno-histochemical analysis of renal glucocorticoid receptor expression in idiopathic nephrotic syndrome
Journal: Nephrologie & therapeutique
Published: September 24, 2026
Primary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy.
Journal: Antibodies (Basel, Switzerland)
Published: August 29, 2026
A Case of Minimal Change Disease in a Patient Receiving Immune Checkpoint Inhibitor.
Journal: Cureus
Published: August 25, 2026
Podocyte dysfunction in kidney diseases: Mechanisms and therapeutic advances.
Journal: Science progress
Published: August 10, 2026
Switching Beyond Rituximab in Primary Glomerular Diseases: A Systematic Review of Within-Patient Efficacy and Safety of Non-Rituximab Anti-CD20 Antibodies.
Journal: Antibodies (Basel, Switzerland)
Published: August 04, 2026
Last Updated: 11/08/2026